AMR Alliance Follows Up Global Industry Standard With Responsible Manufacturing Certification
BSI Certification Is Open To Any Manufacturer, For Any Drug
A new voluntary certification from the AMR Industry Alliance and the British Standards Institution will assess pharmaceutical firms’ responsibility and sustainability when it comes to manufacturing antibiotic drugs, in an attempt to control the spread of antimicrobial resistance.
You may also be interested in...
The AMR Industry Alliance has put forward six different policy proposals which it says could minimize the global impact of antimicrobial resistance.
BioFactura has completed a successful Phase I trial of its Stelara (ustekinumab) biosimilar BFI-751, which is expected to file in developed markets in 2026.
Generics industry trade group Medicines for Europe has met with Ukrainian government officials to discuss how to plan for any future integration process.